Class IIOngoing
Biomerieux Inc recalls VITEK 2 AST-N461 TEST KIT
Recall date · record updated Sep 30, 2026 · Source: U.S. Food and Drug Administration (openFDA device enforcement)
Check your product against the names and codes above. The FDA enforcement record lists the recall as voluntary: firm initiated; it does not state a consumer remedy, so follow the firm’s notice or the FDA link.
- Company
- Biomerieux Inc
- Reason
- The issue is related to card pouch damage associated with a portion of the lot which was produced on a specific card pouching device, in a specific timeframe, causing a potential risk of false resistant results. False resistant results may lead to the use of less effective antibiotic treatments or the association of multiple antibiotics having negative side effects, which could potentially impact patient s health.
- Hazard
- FDA Class II: may cause temporary or medically reversible adverse health consequences (FDA definition).
- Who’s affected
- International distribution to the countries of Austria, Germany, Luxembourg.
- Official notice
- www.accessdata.fda.gov/scripts/ires/index.cfm?Event=99749…
Products
VITEK 2 AST-N461 TEST KIT, GRAM NEGATIVE SUSCEPTIBILITY TESTING - AUTOMATED, Reference Number 424811
Codes/lots: UDI-DI 03573026637712; Lot Number 1333393504Quantity: 97680 unitsRecall no. Z-3231-2026Class II
Update history
- First listed on OVERLOOKED from the official record.
When the agency expands or changes this recall, we update this page and log the change here.
Proof: raw official record (JSON) · fetched from FDA API
More Medicines & devices recalls
Medicines & devicesClass I
Par Health USA, LLC recalls 2 products
Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution.
· FDA · Nationwide
Medicines & devicesClass II
Right Value Drug Stores LLC recalls Testosterone Cypionate
Lack of sterility assurance.
· FDA · Nationwide
Medicines & devicesClass II
STRIDES PHARMA INC recalls Cinacalcet Tablets
Failed dissolution specifications
· FDA · Nationwide